We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+13.6%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$1.16B
AUM Growth
+$73.7M
Cap. Flow
+$24.1M
Cap. Flow %
2.08%
Top 10 Hldgs %
27.51%
Holding
208
New
17
Increased
35
Reduced
30
Closed
120

Top Buys

Rank Stock Value
1
LH icon
Labcorp
LH
+$29.5M
2
RCUS icon
Arcus Biosciences
RCUS
+$20.6M
3
RVMD icon
Revolution Medicines
RVMD
+$17.5M
4
AFIB
Acutus Medical Inc
AFIB
+$16.2M
5
AMWL icon
American Well
AMWL
+$16M

Top Sells

Rank Stock Value
1
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$27.4M
2
APLS
Apellis Pharmaceuticals
APLS
+$25.1M
3
CSII
Cardiovascular Systems, Inc.
CSII
+$20.5M
4
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$17.1M
5
HCAT icon
Health Catalyst
HCAT
+$16.4M

Sector Composition

Rank Sector Weight
1 Healthcare 90.35%
2 Industrials 4.01%
3 Technology 0.1%
4 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRNA icon
51
Moderna
MRNA
$23B
$9.62M 0.83%
135,956
+23,700
+21% +$1.65M
DYN icon
52
Dyne Therapeutics
DYN
$4.76B
$9.58M 0.82%
+474,301
New +$10.4M
PSTX
53
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$9.35M 0.8%
+1,053,779
New +$12M
GH icon
54
Guardant Health
GH
$21.5B
$8.99M 0.77%
80,386
+4,834
+6% +$442K
TSHA icon
55
Taysha Gene Therapies
TSHA
$1.7B
$8.37M 0.72%
+373,775
New +$8.79M
EBS icon
56
Emergent Biosolutions
EBS
$381M
$8.26M 0.71%
79,950
+73,150
+1,076% +$7.89M
ABT icon
57
Abbott
ABT
$182B
$8.02M 0.69%
73,698
– –
UNH icon
58
UnitedHealth
UNH
$376B
$7.94M 0.68%
25,462
-11,052
-30% -$3.39M
KLRS
59
Kalaris Therapeutics
KLRS
$98M
$7.64M 0.66%
+12,078
New +$8.25M
LLY icon
60
Eli Lilly
LLY
$996B
$7.63M 0.66%
51,565
+20,750
+67% +$3.21M
ABBV icon
61
AbbVie
ABBV
$432B
$7.55M 0.65%
86,250
-18,500
-18% -$1.74M
CMPI
62
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
$6.91M 0.59%
+600,687
New +$7.7M
BIIB icon
63
Biogen
BIIB
$29.6B
$6.42M 0.55%
22,632
+16,240
+254% +$4.53M
AMGN icon
64
Amgen
AMGN
$204B
$6.19M 0.53%
24,353
-5,600
-19% -$1.39M
ALXN
65
DELISTED
Alexion Pharmaceuticals
ALXN
$5.87M 0.5%
51,276
-74,500
-59% -$8.04M
MDT icon
66
Medtronic
MDT
$109B
$4.34M 0.37%
41,751
– –
CI icon
67
Cigna
CI
$72.8B
$4.28M 0.37%
25,241
-3,666
-13% -$645K
KYNB
68
Kyntra Bio
KYNB
$27.4M
$4.28M 0.37%
4,160
+3,652
+719% +$3.93M
MRK icon
69
Merck
MRK
$314B
$4.19M 0.36%
52,924
-48,889
-48% -$3.83M
PFE icon
70
Pfizer
PFE
$141B
$4.11M 0.35%
117,943
-114,886
-49% -$4.03M
GILD icon
71
Gilead Sciences
GILD
$161B
$4.1M 0.35%
64,900
-27,250
-30% -$1.89M
NCNA
72
NuCana
NCNA
$5.62M
$3.88M 0.33%
+150
New +$4.06M
TMO icon
73
Thermo Fisher Scientific
TMO
$211B
$3.82M 0.33%
+8,650
New +$3.57M
AMED
74
DELISTED
Amedisys
AMED
$3.74M 0.32%
15,825
– –
OM icon
75
Outset Medical
OM
$93.2M
$3.49M 0.3%
+4,652
New +$3.82M
1 2
3
4 5

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return
BIS
BG Investment Services Hagatna, Guam $120M AUM 17.44% 1-Year Est. Return

Sectoral Asset Management's Q3 2020 Portfolio in Review

As of Q3 2020, Sectoral Asset Management held 208 positions worth $1.16B, up 6.8% from $1.09B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Sectoral Asset Management's Q3 2020 filing shows 17 new, 35 increased, 30 reduced and 120 closed positions. Its largest new stake was Arcus Biosciences: 922,800 shares worth $15.8M. The largest sale was HILL-ROM HOLDINGS, INC., an estimated $27.4M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 86% a quarter earlier, followed by Industrials and Technology.

  • Sectoral Asset Management's largest Q3 2020 buy was Arcus Biosciences: 922,800 shares worth $15.8M.
  • Sectoral Asset Management added most to Labcorp in Q3 2020, an estimated $29.5M increase.
  • Sectoral Asset Management's biggest Q3 2020 reduction was Change Healthcare Inc. Common Stock, cutting an estimated $17.1M.
  • Sectoral Asset Management fully exited HILL-ROM HOLDINGS, INC. in Q3 2020, selling an estimated $27.4M.
  • Sectoral Asset Management's ten largest holdings make up 28% of its $1.16B portfolio in Q3 2020.
  • Sectoral Asset Management opened 17 new positions and closed 120 in Q3 2020.
  • Sectoral Asset Management's portfolio value rose 6.8% quarter-over-quarter to $1.16B.

Based on Sectoral Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.